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Abstract: Free fatty acids serve as important bioactive molecules in the brain. They are involved
in message transfer in the brain. There are many reports available in the literature regarding the role
of cerebral fatty acids in message transfer; however, most of the studies are mainly focused on limited
fatty acid species or only a few specific brain regions. To understand the relationship between
cerebral functions and free fatty acids, it is necessary to investigate the distribution of the free fatty
acids among different regions in the whole brain. In this study, free fatty acids were extracted from
different brain regions and analyzed qualitatively and quantitatively using the stable isotopic labeling
liquid chromatography–mass spectrometry approach. In total, 1008 potential free fatty acids were
detected in the whole brain out of which 38 were found to be commonly present in all brain regions.
Among different brain regions, the highest and the smallest amounts of potential free fatty acids
were detected in the olfactory bulb and cerebellum, respectively. From a statistical point of view,
4-methyl-2-oxovaleric acid, cis-11, 14-eicosadienoic acid, tridecanoic acid, myristic acid, nonadecanoic
acid, and arachidic acid were found to significantly vary among the four different brain regions
(olfactory bulb, occipital lobe, hippocampus, and cerebellum). The variation in the composition of free
fatty acids among different brain regions may be very important for investigating the relationship
between free fatty acids and functions of cerebral regions.
Keywords: fatty acids; brain; liquid chromatography–mass spectrometry method; stable isotope
labeling; regions
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1. Introduction
The brain is a remarkable organ that controls all functions of the body. Based on different
functions, the whole brain can be divided into different regions: the olfactory bulb, which deals
with smelling signals [1,2]; the occipital lobe, which is linked with the visual perception center [3,4];
the hippocampus, which is involved in learning and memory [5]; the cerebellum, which controls
movement [6–8], and so on. Thus, it is obvious that the main function of each brain region varies
significantly. This is because characteristics of cell types of different regions are different from one
another. Similarly, metabolites and signaling molecules of different regions are characteristics of that
specific region.
The diversity in cerebral functions depends on differences in the biochemical composition of each
brain region. Lipids constitute about 50% of the brain’s dry weight and are involved in the brain
structure, signal transmission, and many other functions. Fatty acids belong to lipids and can be
classified in terms of either the length of their carbon chain or the degree of saturation. Based
on their carbon chain length, fatty acids can be classified into a very long chain (>22 C), long chain
(13–22 C), medium chain (6–12 C), and short chain (2–5 C). Whereas in terms of the degree of saturation,
we can classify them into saturated (no C–C double bonds), monounsaturated (1 C–C double bonds),
and polyunsaturated (>1 C–C double bonds). Polyunsaturated fatty acids evidently play an important
role in the brain [9]. For example, docosahexaenoic acid (DHA) is associated with cognition [10–12]
and arachidonic acid (AA) is involved in brain development [9]. AA can esterify cholesterol [13,14] and
metabolizes into some eicosanoids, which are involved in the inflammatory response [15,16]. Protectin
D1, a metabolite of DHA, is an anti-inflammatory agent [17]. Free fatty acids (FFAs) also affect signal
transmission as second messengers [18,19]. A metabolite of AA, 12-Hydroxyeicosatetraenoic acid,
is a neuromodulator that can protect neurons from excitotoxicity by activating a Gi/o-protein-coupled
receptor [20]. Thus, qualitative and quantitative analysis of regional cerebral free fatty acids is
very important for investigating cerebral functions. Furthermore, free fatty acids can also make up
more complex lipids, such as phospholipids, which make up the cytoskeleton. Progression of many
neurological diseases is accompanied by phospholipid abnormalities [21–24]. Phospholipids can
release fatty acids by the phospholipase activity on the cell membrane [25].
Many reports are available in the literature that show the contents of FFAs in the brain. However,
only a few have focused on types of FFAs or brain regions [26,27]. The diversity and distribution
of free fatty acids in all brain regions have not yet been fully explored. It is, therefore, necessary
to analyze the FFAs of all brain regions in order to understand the functions of various regions.
For exploring the various brain functions, a variety of fatty acids are required; nevertheless, the brain
tissues containing these fatty acids are limited. The mass of different brain regions varies. For example,
the olfactory bulb of an adult rat weighs less than 100 mg, which is not easy to examine. In order
to study the maximum possible types of fatty acids, a highly sensitive method is needed. Chemical
isotope labeling liquid chromatography–mass spectrometry (CIL-LC-MS) is a suitable technique for
this [28]. Utilizing this method, prior to LC-MS analysis, a pair of isotope-coded reagents is used to
react with a specific functional group to form derivatives. The derivatives enhance the ionization
efficiency in an Electrospray Ionizer (ESI) due to the addition of an easily ionizable group onto
the target compounds. This also improves selectivity by introducing an isotope tag onto the structure.
This method has been applied in various samples for less abundant targets.
To explore how free fatty acids are distributed in different brain regions, the rat brain was divided
into 12 different brain regions and the medulla oblongata was selected as the research material.
Ultimately, all regions were studied using qualitative and quantitative methods of FFAs for processing
CIL-LC-MS data. In the whole brain, a total of 1008 potential FFAs were detected. The classes of FFAs
can vary from region to region. The variation in the contents of FFAs in four different brain regions
were further investigated. Six positively identified FFAs were statistically significantly different.
The regional specificity of FFAs can be linked to differences in brain functions. This study could reveal
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a more comprehensive understanding of the distribution of FFAs in brain regions, thereby providing
a reference for subsequent studies.
2. Results and Discussion
2.1. Screening and Identification of FFAs in Different Brain Regions
FFAs were firstly screened and qualitatively identified in all regions by the CIL-LC-MS method,
which has been described in detail in our previous work [28]. The supernatant of 100 mg tissue
from each region was equally divided into two parts and the two parts were labeled with DMED
or d4-DMED, respectively. The labeled samples were mixed together before LC-MS analysis. The total
ion chromatograms of the full scan are shown in Figure 1A. A potential fatty acid was detected as
paired-peaks with the same retention index, similar intensities, and defined mass difference of 4.025.
For example, the extracted ion chromatograms at m/z 215.2118/219.2369 have the same RIs and similar
peak intensities (Figure 1C), which are considered as a potential fatty acid. In addition, precursor ions
of the peak pairs were further confirmed by MS spectra of DMED/d4-DMED labeled samples (Figure 1B).
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Figure 1. An example for the steps of identification of metabolites in brain extracts with the chemical
isotope-labeled method using LC-MS under the full scan mode. (A) Total ion chromatograms (TIC)
of the DMED/d4-DMED-labeled brain sample. (B) Mass spectra of DMED/d4-DMED-labeled caprylic
acid. (C) Extracted ion chromatograms (EIC) of caprylic acid at m/z 215.2118 and 219.2369 from
DMED/d4-DMED-labeled brain sample.
Finally, a total of 1008 potential FFAs were found in the whole brain. Detailed information is
provided in Table S1. Among different brain regions, the following number of FFAs were detected:
686 in the OB, 449 in FC, 416 in PC, 450 in OC, 410 in TC, 414 in STR, 562 in THA, 525 in HYP, 489
in MID, 388 in CE, 460 in HP, 451 in BS, and 547 in the medulla. Furthermore, the number of FFAs
of all brain regions are summarized in Figure 2. The OB has more free fatty acids than all the other
regions and is an important part of the olfactory system especially for rodents. Rodents’ feeding and
reproduction are dependent on the olfactory bulb. There are various cell subtypes to handle the variety
of information received from the environment. It could be hypothesized that this large amount and
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various types of FFAs are probably needed to form various molecules to fulfil the higher demand
on the OB as compared to the other regions.
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Figure 2. Total species of free fatty acids among different brain regions. Note: OB—olfactory
bulb; FC—frontal cortex; PC—parietal cortex; OC occipital cortex; TC—temporal cortex;
HP—hippocampus; STR—stri tum MID—midbrain; THA— halamus; HYP—hypothalamus;
CE—cerebellum; MEA—medulla-pons; BS—brainstem. OB has the largest types of fatty acids
and CE has the least types of fatty acids.
FFAs detected in the whole brain have been explained according to their specific region and relative
concentrations. Prospective molecular formulas of potential FFAs were generated based on accurate
m/z using the Thermo Xcalibur 2.1 Software. Annotation was performed as follows: the information
(RI, accurate m/z) of detected paired peaks was compared to in-house chemically labeled standards
library (http://59.110.238.58/search.php?tdsourcetag=s_pctim_aiomsg). A total of 56 peak pairs were
matched with library data (No. 1–56 in Table S1) of which 38 of FFAs were found to be present
in every region (highlighted in the Table S1). There were 18 saturated fatty acids, six monounsaturated
fatty acids, 10 polyunsaturated fatty acids (PUFAs), and four bile acids. A total of 10 PUFAs were
found to be present in every region, since they play an important role in the brain. Bile acids may be
transferred to the brain through the blood or hepatic gut brain axis, which is consistent with a previous
study [29,30]. Further research is needed to examine the potential function of bile acids in the brain.
Remaining peak pairs were assigned by searching the molecular formulas in the METLIN database
(https://metlin.scripps.edu/landing page.php) and 339 peak pairs matched to one or more chemical
structures (No. 57–395 in Table S1). Formulae for 613 out of 1008 detected peak pairs were not found
in the METLIN database. This suggests that there may be some new fatty acids existing in the brain
that require further investigation (No. 396–1008 in Table S1).
2.2. Common FFAs between Two Regions
The species of FFAs were compared between two different brain regions with each pair (Figure 3).
There were similar fatty acids between two different brain regions, which are common FFAs. THA and
OB have 447 common potential fatty acids (the most common pair). The total number of fatty acids
present commonly in HYP and OB, THA and HYP, and MEA and THA were found to be more than 400.
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The regions with less than 300 common fatty acids were found to be BS and TC, HYP and CE, and BS
and CE. The common fatty acids of OB vs. THA, HYP, and MEA are more than in the other regions.
That may relate to the function that the two regions participate in: THA mediates visceral-somatic
reflex activity, which is associated with the sense of smell and part of it is connected to OB whereas;
HYP is related to feeding which depends on the sense of smell in rats [31–33]. The mutual function
of two different brain regions may lead to similar composition. That might be the reason they have
more common fatty acids.
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Figure 3. A heat map of common fat y i t een two different brain regions.
Howev r, we cannot deny the fact that these re i re fa ty acids within them, which
makes it easier to match tt acids with the other regions. Thus, the ra io of the number
of A region divi ed by co mon FFAs amounting to between A and B is more likely to show a similarity
to A region and B region. Figure 4 shows the percentage of co on fatty acids between two different
regions divided by the vertical shaft region’s potential fatty acids. For instance, 0.78 from the first
column and second row in Figure 4 means the common FFAs between FC and OB are 78% of the FFAs
in FC. The common FFAs are 51% of the FFAs in OB (first row and second column in Figure 4).
We demonstrated that the OB and most of the other regions have a higher proportion of common fatty
acids vs. the region being compared, while they have a lower proportion vs. the OB. Nearly all regions
and CE have a higher proportion of common fatty acids vs. CE. This may be due to the fact that the OB
has the most abundant free fatty acids compared to the other regions, while CE has the least. This factor
can also explain why common free fatty acids of OB vs. THA, HYP, and MEA are apparently more
than others.
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Eicosadienoic acid (∆11,1 - : ; ) is aturally occurring n-6 polyunsaturated fatty acid
(PUFA) and can modulate the metabolism of PUFA and change the responsiveness of macrophages to an
inflammatory stimulation [34]. EDA was found to be different between moderating Alzheimer’s disease
(AD) or dementia with Lewy bodies and cognitively normal age-matched controls [35]. Ketoleucine,
also known as 4-Methyl-2-oxovaleric acid, arises from the incomplete breakdown of branched-chain
amino acids and acts both as a neurotoxin and a metabotoxin. Maple syrup urine disease (MSUD)
is associated with chronically high levels of ketoleucine. Without treatment, it leads to severe brain
damage in infancy and abnormal behaviors and moods in older individuals [36]. Ketoleucine was
reported to be higher in the cerebrospinal fluid from Amyotrophic lateral sclerosis or Parkinson’s disease
patients [37]. The content difference of free fatty acids may relate to the difference in regional activity.
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3. Material and Method
3.1. Study Design
A total of 12 different cerebral regions and medulla of rats were selected as study
materials. The CIL-LC-MS technique was employed for qualitative and quantitative investigation
of the variations in types and contents of FFAs in different brain regions. A pair of isotopic probes
(2-dimethylaminoethylamine (DMED) and d4-2-dimethylaminoethylamine (d4-DMED)) containing
carboxylic acid reactive group, were used to label free fatty acids, based on amidation. The detailed
workflow of the current work is shown in Figure 7.
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Figure 7. Workflow for determination of fatty acids in rat brain by the chemical isotope labeling liquid
chromatography–mass spectrometry (CIL-LC-MS) method; 2-dimethylaminoethylamine (DMED) and
d4-2-dimethylaminoethylamine (d4-DMED) were utilized to facile label free fatty acids. L, DMED
labeled peaks; H, d4-DMED labeled peaks; “*” means a pair of peaks that will be extracted as a potential
fatty acid.
3.2. Chemicals and Reagents
All fatty acid standards were pu chase from Sigma (St. Louis, MO, USA) and J&K Chemical
(Beijing, China). Analytical grade formic acid (FA), ethyl acetate (EA), triethylamine (TEA),
2-chloro-1-methylpyridinium iodide (CMPI), and DMED were obtained from Sinopharm Chemical
Reagent Co., Ltd. (Shanghai, China). Isotope labeling reagent of d4-DMED was synthesized according
to our previously reported method [27]. HPLC-grade acetonitrile (ACN) and methanol were purchased
from TEDIA Co., Inc (Fairfield, OH, USA). Water used for analysis was purified by a Milli-Q
apparatu (Millipore, Milford, CT, USA). Stock solutions of TEA (20 mmol/L), CMPI (20 mmol/L),
DMED (40 mmol/L), and d4-DMED (40 mmol/L) were prepared in HPLC-grade ACN. Stock solutions
of standard organic acids were prepared in HPLC-grade ACN with a concentration of 1.0 mg/mL for
each and stored at −20 ◦C until analyzed.
3.3. Brain Sample Collection and Pre-Treatment
The exp riments were app ed by the Animal Ethics C mmi tee t th Wuhan Institute of Physics
and Mathematics and met all the prescribed guidelines. Fifteen Sprague Dawley male rats (3 for
the qualitative study and 12 for the quantitative study) were purchased from the Center for Disease
Control of Hubei Province and adapted to the environment for a week in an animal facility with
regulated temperature, humidity, and light cycle and with free access to water and food. The age of rats
was around seven weeks old and the weight between 200 and 220 g at the start of the experiment.
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On the experimental day, three animals were initially anesthetized with overdose of isoflurane,
and the level of anesthesia was verified with a pinch applied to the hind leg. After that, three
anesthetized animals were euthanized with the head-focused microwave method using a commercially
available microwave machine (1 kW, Tangshan Nanosource Microwave Thermal Instrument
Manufacturing Co. Ltd., Hebei, China). The microwave method was used in this study to avoid
post-mortem release of fatty acids [9], since Farias reported that AA increased 18-fold after brain
ischemia [38]. Post-mortem release of fatty acids may lead to a substantial increase in concentration
of some FFAs. This can result in further increase in peaks of some fatty acids, which may suppress
the other nearby fatty acid peaks. After cooling down the rat head to room temperature with dry ice,
the whole brain was collected and manually dissected into 13 different brain regions. The dissected
brain regions were: olfactory bulb (OB), frontal lobe (FC), parietal lobe (PC), occipital lobe (OC),
temporal lobe (TC), hippocampal (HP), thalamus (THA), hypothalamic (HYP), midbrain (MID),
striatum (STR), cerebellum (CE), medulla (MEA), and brainstem (BS). All samples were weighed and
stored at −80 ◦C until further analysis. In order to decrease the variability among the different animals,
brain samples from the same region of different animals were pooled together and transferred to a 5 mL
centrifuge tube. Then, 1mL pre-cooled saline solution was added and the mixture grinded in an ice
bath. After that, 2 mL of EA was further added, and the mixture vortexed for 3 min for the extraction
of fatty acids. The resulting mixture was centrifuged at 13,000 g for 3 min at 4 ◦C, and the supernatant
was collected. The extraction procedure with EA was repeated twice, and the supernatants were
combined together and vortexed again. The supernatants were transferred to a new centrifuge tube
according to the brain weight ensuring that the transferred liquid was extracted from 100 mg of tissue.
The transferred supernatants were dried under nitrogen gas and residues were used for subsequent
chemical labeling.
Twelve rats were anesthetized with an overdose of isoflurane and then decapitated. The Microwave
method was not applied here in order to avoid any possible chemical changes in free fatty acids.
The brain was separated, collected quickly, and put above the dry ice in order to be dissected into
different regions. The samples were stored at −80 ◦C for further analysis after flash-freezing with
liquid nitrogen. The four representative cerebral regions OB, HP, OC, and CE were grinded on dry
ice independently, centrifuged, and the supernatants collected by following the same procedure as
in the previous step. The collected supernatant extracted from 20 mg of each sample was then dried
under nitrogen gas. A quality control (QC) sample was prepared by equally mixing brain samples
from four different regions.
3.4. Labeling of Free Fatty Acids with DMED and d4-DMED
For qualitative analysis, the labeling of DMED and d4-DMED was performed by following
a previously described method [27,28]. The specific labeling process was as follows: 200 µL ACN
was added to brain residues and the mixtures vortexed for 3 min. The mixture was divided into two
equal parts. A 20 µL of TEA (20 mmol/L) and 10 µL CMPI (20 mmol/L) were added to the solution
then vortexed and incubated at 40 ◦C for 5 min. Then 20 µL of DMED (40 mmol/L) or 20 µL d4-DMED
(40 mmol/L) was added, and the solution was incubated at 40 ◦C for 1 h. The resulting solution
was dried under nitrogen and re-dissolved in 100 µL ACN/water (v/v, 1/9) and left for LC-Orbitrap
MS analysis.
For relative quantitative analysis, samples were labelled with DMED by following the above
described procedure. To overcome the error caused by retention time drifts in LC analysis, retention
indices were adopted for correction by adding straight-chain n-alkanoic acids (C5:0-C24:0) labeled
by d4-DMED.
3.5. UPLC-MS Analysis
Brain samples were analyzed using the Ultra Performance Liquid Chromatography
(UPLC)-LTQ-Orbitrap MS system consisting of a LTQ-Orbitrap Elite mass spectrometer (Thermo
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Scientific, Waltham, MA, USA) with an electrospray ionization source and a Dionex Ultimate
3000 UHPLC system (Thermo Scientific, Sunnyvale, CA, USA). Data acquisition and processing
were performed with Thermo Xcalibur Software (version 2.1, Thermo Fisher Scientific, Inc., Waltham,
MA, USA). An Acquity UPLC BEH C18 Column (2.1 × 50 mm, 1.7 µm, Waters, Milford, CT, USA) was
used for HPLC separation with a flow rate of 0.4 mL/min at 40 ◦C. FA in water (0.1%, v/v, solvent A),
and ACN (solvent B) was used as mobile phases. A gradient of 0–5 min at 5% B, 5–48 min from 5 to 95%
B, 48–53 min at 95% B, 53–55 min from 95 to 5% B, and 55–60 min at 5% B was applied. The injection
volume was 10 µL. The labeled samples were detected in positive ion full scan mode in the range
of m/z 180–650 at resolution of 60,000. ESI conditions employed were as follows: capillary temperature,
350 ◦C; spray voltage, 3.5 kV; sheath gas flow, 35 arbitrary; auxiliary gas flow, 15 arbitrary; heater
temperature, 300 ◦C.
3.6. Data Analysis
Thermo sieve 2.1 Software (Thermo Fisher Scientific, Waltham, MA, USA) was used to extract
MS spectral peaks of raw data to generate the information about detected fatty acid compounds with
accurate m/z, peak intensity, and retention time (RT). RTs were calibrated by retention indices (RIs)
as reported [28] to overcome the drifting of retention times. Peak pairs extraction was operated with
4.025 Da mass difference, similar peak intensities and RIs by using an in-house MATLAB-based software.
Prospective molecular formulas of DMED-labeled fatty acids were generated based on the accurate
m/z using the Thermo Xcalibur 2.1 Software. Mass tolerance of 5.0 mDa was set, and the elements C,
H, N, and O were used. In-house chemically labeled standards library (http://59.110.238.58/search.
php?tdsourcetag=s_pctim_aiomsg) was employed for fatty acids identification from brain samples.
Principal component analysis (PCA) and orthogonal partial least squares–discriminant analysis
(OPLS-DA) were used for the exploratory analysis of the data of relative concentrations by using SIMCA
14.1 Software (Umetrics AB, Umea, Sweden). IBM SPSS statistics 19.0 was performed for one-way
ANOVA analysis. Variable importance for projection (VIP) value of OPLS-DA model more than 1.0
and p-value obtained by one-way ANOVA less than 0.05 were considered as statistically significant
difference of fatty acids. Parts data were dealt with using data transformations (square-root or base-10
logs) to make variables fit a normal distribution and homoscedascity test before one-way ANOVA.
4. Conclusions
The CIL-LC-MS technique was applied to analyze free fatty acids in 12 brain regions and
the medulla. At the end, a total of 1008 potential free fatty acids were found in the whole brain,
and of those, 56 fatty acids were positively identified. Thirty-eight out of 56 were found to be common
free fatty acids present in every brain region. Among different brain regions, the olfactory bulb contains
the most abundant fatty acids, while the cerebellum has the least. Different cortex parts have similar
amounts but different species of fatty acids. In addition, we quantitatively explored the distribution
of fatty acids in the OB, OC, HP, and CE. Six fatty acids were found to be significantly different.
The compositions of the fatty acids varied among different regions. This study may provide a more
comprehensive understanding of the distribution of fatty acids in brain regions and thus provide
important information for neurochemical studies.
Supplementary Materials: The following are available online, Table S1: Content of the detected potential fatty
acids in brain.
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